참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Norethisterone Acetate | HCID 5832 | — |
| 반응물 | Progesterone | HCID 5994 | — |
| 반응물 | Norethindrone | HCID 6230 | — |
| 반응물 | Norethynodrel | HCID 6231 | — |
| 반응물 | Dydrogesterone | HCID 9051 | — |
| 반응물 | Ethynodiol Diacetate | HCID 9270 | — |
| 반응물 | Levonorgestrel | HCID 13109 | — |
| 반응물 | Dimethisterone Monohydrate | HCID 65320 | — |
| 반응물 | acetic acid;(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one | HCID 66742607 | — |
| 반응물 | acetic acid;(8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one | HCID 131710941 | — |
| 생성물 | 3-Oxo-17beta(1oxopropoxy)androst-4en-19-al | HCID 86734575 | — |
반응 단계
The composition of claim 25 wherein the progestogen is 17-hydroxy-19-nor-17α-pregn-4-en-20yn-3-one, 17-hydroxy-19-nor-17α-pregn-4-en-20-yn-3-one acetate, 17-hydroxy-19-nor-17α-pregn-5(10)en-20-yn-3-one, 17-hydroxy-19-nor-17α-pregn-4-en-20-yn, 19-nor-17α-pregn-4-en-20-yne-3β,17-diol diacetate, 3-cyclopentyloxy-19-nor-17α-pregna-3,5-diene-20-yn-17-ol acetate, 16α(R),17-](1phenylethylidene)bis(oxy)]pregn-4-ene-3,20-dione, 17-hydroxy-6α-methylpregn-4-ene-3,20-dione acetate, 17α-hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate, 17α-hydroxy-6-methyl-16-methylene-4,6-diene-3,20-dione acetate, 17β-hydroxy-6α-methyl-17-(1-propynyl)androst-4-en-3-one monohydrate, 13-ethyl-17-hydroxy-18,19-dinor-17α-pregn-4-en-20-yn-3-one, or 9β,10α-pregna-4,6-diene-3,20-dione.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US04054651 |
|---|
| 출처 데이터셋 | uspto-grants-1977_10 |
|---|
| ORD ID | ord-b4931d9b65a3428f98c87b516a03f09a |
|---|
| 출처 메모 | uspto-grants-1977_10 |
|---|
